Chamber and committees

Scottish Government officials have been involved in initial discussions with academics and clinicians about the potential for a Scottish research study of newborn screening for Spinal Muscular Atrophy (SMA), and are awaiting a fully developed proposal. Any decision thereafter to run an SMA pilot will depend on the expert advice of the Scottish Screening Committee as well as the organisations that oversee implementation of any changes to the newborn screening programme.

Scottish Qualifications Authority (SQA) is an executive Non-Departmental Public Body (NDPB), established under the Education (Scotland) Act 1996. It operates at arm’s length to Ministers and is responsible for making its own evidentially based operational decisions.

I have asked the SQA to reply.

SQA has advised that it does not employ psychologists and their guidance draws on a range of teams and specialisms.

Alcohol and drug-related harms are important public health issues in Scotland, which is why we established a national mission to improve and save lives. At the core of which is ensuring that every individual is able to access the treatment and recovery they choose.

We are working to ensure people with alcohol use disorder continue to receive the same quality of care as those with drugs misuse. The forthcoming Alcohol Treatment Guidelines will provide support for alcohol treatment, similar to the Medication-Assisted Treatment Standards for drugs. We are also developing alcohol treatment targets alongside Stage Two of the Drugs Targets Implementation in 2024.

We announced £100 million of additional investment to increase the availability of residential rehabilitation, that will benefit people experiencing alcohol and/or drug addiction.

On 06 December 2021, we launched a campaign to address stigma experienced by people with problematic alcohol and drug use. The campaign ran across multiple media platforms.

I have asked the Scottish Qualifications Authority (SQA) to reply.

While information is available for children and young people with additional support needs, neither Scottish Government nor SQA collect specific data on candidates who may have a neuro-divergent diagnosis. The Education (Additional Support for Learning) Act 2004 (as amended) requires education authorities to identify, provide for and review the additional support needs of their pupils. The provision of additional support is based on need for educational support rather than a diagnosis alone.

Where a school is presenting a candidate with additional support needs for examination, if appropriate, a request can be made to SQA for a reasonable adjustment, such as additional time or a scribe. The requests from centres do not require or provide any detail on the range of additional support needs or disabilities that learners have.

The Scottish Government welcomed the publication of this report and is considering its conclusions and any actions to be taken, whether nationally or locally, as a result of the research findings. In particular, the information will inform our ongoing response to the COVID-19 pandemic in areas such as antenatal education, telecare and visiting.

We published our maternity and neonatal visiting guidance Coronavirus (COVID-19): hospital visiting guidance - gov.scot (www.gov.scot) which aligns with wider NHS guidance and the lifting of restrictions, and includes advice on partner and sibling visiting.

In the five financial years from 2017-18 to 2021-22, the Scottish Government provided a total of £330,500 in grant funding to the Royal Highland Education Trust (RHET) for the purposes of their programme of school farm visits and associated educational resources for schools.

These grants are applied for and awarded on an annual basis. It is therefore not possible at this time to estimate accurately how much might be provided in funding over the next five financial years.

The Scottish Government does not facilitate any forums or roundtables for self-employed inventors. We are working with industry and key stakeholders to develop a new innovation strategy to ensure businesses, people and institutions are ready to meet the challenges and opportunities we face over the next 10 years. We will ensure the support we provide is easy to access and focused on areas of greatest opportunity to meet our vision in becoming a world leading, innovation nation.

The cost of grid infrastructure enhancements is an area of policy reserved to the UK Government. The recent Ofgem reform will mean that from the 1st of April 2023 generation and storage will pay less upfront costs and some of these costs will be socialised across the relevant network.

The Scottish Government wishes to see network costs reformed to support greater uptake of renewables generation and storage. However, this cannot done at the expense of financially vulnerable and fuel poor.

Those most vulnerable are already experiencing difficulties due to the cost of living energy crisis and care needs to be taken to ensure that those least able to pay do not end up paying the costs for those who can afford domestic generation and storage.

The Scottish Government will continue to make the case for comprehensive reform of network charges that supports delivery of net zero at the lowest cost to the consumer.

The Chief Scientist Office (CSO) provides funding to support and facilitate high quality applied research across a wide health and care remit

CSO Approach to Funding – Chief Scientist Office (scot.nhs.uk)

This includes funding in support of research in areas of public health, or health and care where delivery may be outside of clinical settings

CSO's annual budget from 2012-13 to 2022-23 is provided below:

2012-13 £67.9 million

2013-14 £68.3 million

2014-15 £68.5 million

2015-16 £66.8 million

2016-17 £64.8 million

2017-18 £64.4 million

2018-19 £67.2 million

2019-20 £69.9 million

2020-21 £69.9 million

2021-22 £75.4 million (includes £3.5 million non-recurring COVID-19 funding)

2022-23 £78.4 million

The Young Patients Family Fund provides valuable financial support to eligible visitors of inpatients up to the age of 18. There are currently no plans to extend eligibility for outpatient treatment.